Air pollution: An environmental factor contributing to intestinal disease

Journal of Crohn's and Colitis

Volumn 5, Issue 4, 2011, Pages 279-286

  Beamish, Leigh A ^a   Osornio Vargas, Alvaro R ^a   Wine, Eytan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Air pollution; Inflammatory bowel diseases; Intestinal inflammation; Microbiota; Particulate matter

Indexed keywords

CARBON MONOXIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; FOSSIL FUEL; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; METAL; NICOTINE; NITRATE; NITROGEN DIOXIDE; ORGANIC CARBON; OZONE; POLYCYCLIC AROMATIC HYDROCARBON; SULFATE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; VOLATILE ORGANIC COMPOUND;

AIR POLLUTANT; AIR POLLUTION; AIR QUALITY; APPENDICITIS; ASTHMA; AUTOPHAGY; BIOINFORMATICS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COMBUSTION; CROHN DISEASE; DIARRHEA; DIET; DIGESTIVE SYSTEM CANCER; DISEASE EXACERBATION; EMERGENCY WARD; ENTEROPATHY; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EXHAUST GAS; EXPOSURE; FOOD CONTAMINATION; GAS; GENE; HEREDITY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYGIENE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INDUSTRIALIZATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE; INTESTINE FLORA; INTESTINE INJURY; LEUKOCYTE; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG FUNCTION; METAGENOMICS; MORBIDITY; MORTALITY; MUCOCILIARY CLEARANCE; MULTIPLE SCLEROSIS; NONHUMAN; OCCUPATION; OXIDATIVE STRESS; PARTICULATE MATTER; PET ANIMAL; POLLEN; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; URBAN AREA; VEGETABLE; VOMITING; WATER CONTAMINATION; WHEEZING; WINTER;

AIR POLLUTION; ENVIRONMENTAL EXPOSURE; HUMANS; INFLAMMATORY BOWEL DISEASES; PARTICULATE MATTER; SMOKING;

EID: 79958813766     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.02.017     Document Type: Review

References (79)

1. Laumbach R.J. Outdoor air pollutants and patient health. Am Fam Physician 2010, 81:175-180.
2. World Health Organization WHO air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide 2006, World Health Organization.
3. Brunekreef B., Holgate S.T. Air pollution and health. Lancet 2002, 360:1233-1242.
4. Dockery D.W., Pope C.A. Spiezer FE. Effects of particulate air pollution exposures. Particle-lung interactions 2000, 671-698. Marcel Decker, Inc., New York. P. Gehr, J. Heyder (Eds.).
5. Fan Z.T., Meng Q., Weisel C., et al. Acute exposure to elevated PM2.5 generated by traffic and cardiopulmonary health effects in healthy older adults. J Expo Sci Environ Epidemiol 2009, 19:525-533.
6. Rojas-Martinez R., Perez-Padilla R., Olaiz-Fernandez G., et al. Lung function growth in children with long-term exposure to air pollutants in Mexico City. Am J Respir Crit Care Med 2007, 176:377-384.
7. Atkinson R.W., Anderson H.R., Sunyer J., et al. Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air pollution and health: a European approach. Am J Respir Crit Care Med 2001, 164:1860-1866.
8. Brook R.D., Rajagopalan S., Pope C.A., et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010, 121:2331-2378.
9. European Commission Scientific Committee on Food Opinion on the scientific committee on food on the risk to human health of polycyclic aromatic hydrocarbons in food 2002, European Commission, Brussels, Belgium.
10. Kreyling W.G., Blanchard J.D., Godleski J.J., et al. Anatomic localization of 24- and 96-h particle retention in canine airways. J Appl Physiol 1999, 87:269-284.
11. Moller W., Haussinger K., Winkler-Heil R., et al. Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects. J Appl Physiol 2004, 97:2200-2206.
12. Vidgren M., Waldrep J.C., Arppe J., et al. A study of 99mtechnetium-labelled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers. Int J Pharm 1995, 115:209-216.
13. Calderon-Garciduenas L., Franco-Lira M., Torres-Jardon R., et al. Pediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology. Toxicol Pathol 2007, 35:154-162.
14. Calvert G.M., Ward E., Schnorr T.M., Fine L.J. Cancer risks among workers exposed to metalworking fluids: a systematic review. Am J Ind Med 1998, 33:282-292.
15. Garcia-Perez J., Lopez-Cima M.F., Perez-Gomez B., et al. Mortality due to tumours of the digestive system in towns lying in the vicinity of metal production and processing installations. Sci Total Environ 2010, 408:3102-3112.
16. Jerrett M., Burnett R.T., Ma R., et al. Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology 2005, 16:727-736.
17. Mills P.K., Abbey D., Beeson W.L., Petersen F. Ambient air pollution and cancer in California Seventh-day Adventists. Arch Environ Health 1991, 46:271-280.
18. Kaplan G.G., Dixon E., Panaccione R., et al. Effect of ambient air pollution on the incidence of appendicitis. CMAJ 2009, 181:591-597.
19. Orazzo F., Nespoli L., Ito K., et al. Air pollution, aeroallergens, and emergency room visits for acute respiratory diseases and gastroenteric disorders among young children in six Italian cities. Environ Health Perspect 2009, 117:1780-1785.
20. Lipsett M., Hurley S., Ostro B. Air pollution and emergency room visits for asthma in Santa Clara County, California. Environ Health Perspect 1997, 105:216-222.
21. Kaplan G.G., Hubbard J., Korzenik J., et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol 2010, 105:2412-2419.
22. Ananthakrishnan A.N., McGinley E.L., Binion D.G., Saeian K. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: An ecologic analysis. Inflamm Bowel Dis 2011, 17:1138-1145.
23. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008, 8:458-466.
24. Malaty H.M., Fan X., Opekun A.R., Thibodeaux C., Ferry G.D. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr 2010, 50:27-31.
25. Benchimol E.I., Guttmann A., Griffiths A.M., et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009, 58:1490-1497.
26. Gearry R.B., Richardson A.K., Frampton C.M., Dodgshun A.J., Barclay M.L. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010, 25:325-333.
27. Oikonen M., Laaksonen M., Laippala P., et al. Ambient air quality and occurrence of multiple sclerosis relapse. Neuroepidemiology 2003, 22:95-99.
28. van der Heide F., Nolte I.M., Kleibeuker J.H., Wijmenga C., Dijkstra G., Weersma R.K. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease. Am J Gastroenterol 2010, 105:1165-1172.
29. Lapanje A., Rupnik M., Drobne D. Gut bacterial community structure (Porcellio scaber, Isopoda, Crustacea) as a measure of community level response to long-term and short-term metal pollution. Environ Toxicol Chem 2007, 26:755-763.
30. Stern S.T., Johnson D.N. Role for nanomaterial-autophagy interaction in neurodegenerative disease. Autophagy 2008, 4:1097-1100.
31. Lakatos P.L., Szamosi T., Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly?. World J Gastroenterol 2007, 13:6134-6139.
32. van der Heide F., Dijkstra A., Albersnagel F.A., Kleibeuker J.H., Dijkstra G. Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis. J Crohns Colitis 2010, 4:125-131.
33. Pullan R.D., Rhodes J., Ganesh S., et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994, 330:811-815.
34. Birrenbach T., Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004, 10:848-859.
35. Grigg J. Particulate matter exposure in children: relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009, 6:564-569.
36. Invernizzi G., Ruprecht A., Mazza R., et al. Particulate matter from tobacco versus diesel car exhaust: an educational perspective. Tob Control 2004, 13:219-221.
37. Osornio-Vargas A.R., Serrano J., Rojas-Bracho L., et al. In vitro biological effects of airborne PM(2.5) and PM(10) from a semi-desert city on the Mexico-US border. Chemosphere 2011, 83:618-626.
38. Chen H., Goldberg M.S., Villeneuve P.J. A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Rev Environ Health 2008, 23:243-297.
39. Health Organization Regional Office for E. Air quality guidelines for Europe. Copenhagen 2000, WHO regional publications, Report No.: 1358 3/0378-2255.
40. Lanki T., de Hartog J.J., Heinrich J., et al. Can we identify sources of fine particles responsible for exercise-induced ischemia on days with elevated air pollution? The ULTRA study. Environ Health Perspect 2006, 114:655-660.
41. Bhalla D.K. Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, mechanisms, and implications. J Toxicol Environ Health B Crit Rev 1999, 2:31-86.
42. Maier K.L., Alessandrini F., Beck-Speier I., et al. Health effects of ambient particulate matter-biological mechanisms and inflammatory responses to in vitro and in vivo particle exposures. Inhal Toxicol 2008, 20:319-337.
43. Dockery D.W., Pope C.A., Xu X., et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993, 329:1753-1759.
44. Ling S.H., van Eeden S.F. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009, 4:233-243.
45. Chauhan A.J., Krishna M.T., Frew A.J., Holgate S.T. Exposure to nitrogen dioxide (NO2) and respiratory disease risk. Rev Environ Health 1998, 13:73-90.
46. Alfaro-Moreno E., Martinez L., Garcia-Cuellar C., et al. Biologic effects induced in vitro by PM10 from three different zones of Mexico City. Environ Health Perspect 2002, 110:715-720.
47. Alfaro-Moreno E., Torres V., Miranda J., et al. Induction of IL-6 and inhibition of IL-8 secretion in the human airway cell line Calu-3 by urban particulate matter collected with a modified method of PM sampling. Environ Res 2009, 109:528-535.
48. Happo M.S., Salonen R.O., Halinen A.I., et al. Inflammation and tissue damage in mouse lung by single and repeated dosing of urban air coarse and fine particles collected from six European cities. Inhal Toxicol 2010, 22:402-416.
49. Ovrevik J., Lag M., Holme J.A., Schwarze P.E., Refsnes M. Cytokine and chemokine expression patterns in lung epithelial cells exposed to components characteristic of particulate air pollution. Toxicology 2009, 259:46-53.
50. Xia T., Kovochich M., Nel A. The role of reactive oxygen species and oxidative stress in mediating particulate matter injury. Clin Occup Environ Med 2006, 5:817-836.
51. Manzo N.D., Slade R., Richards J.H., McGee J.K., Martin L.D., Dye J.A. Susceptibility of inflamed alveolar and airway epithelial cells to injury induced by diesel exhaust particles of varying organic carbon content. J Toxicol Environ Health A 2010, 73:565-580.
52. Danielsen P.H., Risom L., Wallin H., et al. DNA damage in rats after a single oral exposure to diesel exhaust particles. Mutat Res 2008, 637:49-55.
53. Iwai K., Adachi S., Takahashi M., et al. Early oxidative DNA damages and late development of lung cancer in diesel exhaust-exposed rats. Environ Res 2000, 84:255-264.
54. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078.
55. Sartor R.B., Sandborn W.J. Kirsner's inflammatory bowel disease 2004, Saunders, Toronto.
56. Hathout E.H., Beeson W.L., Nahab F., Rabadi A., Thomas W., Mace J.W. Role of exposure to air pollutants in the development of type 1 diabetes before and after 5yr of age. Pediatr Diab 2002, 3:184-188.
57. Kleinman M.T., Araujo J.A., Nel A., et al. Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathways. Toxicol Lett 2008, 178:127-130.
58. Seaton A., MacNee W., Donaldson K., Godden D. Particulate air pollution and acute health effects. Lancet 1995, 345:176-178.
59. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347:911-920.
60. Ritz S.A. Air pollution as a potential contributor to the 'epidemic' of autoimmune disease. Med Hypotheses 2010, 74:110-117.
61. Calderon-Garciduenas L., Macias-Parra M., Hoffmann H.J., et al. Immunotoxicity and environment: immunodysregulation and systemic inflammation in children. Toxicol Pathol 2009, 37:161-169.
62. Granum B., Gaarder P.I., Groeng E., Leikvold R., Namork E., Lovik M. Fine particles of widely different composition have an adjuvant effect on the production of allergen-specific antibodies. Toxicol Lett 2001, 118:171-181.
63. Leonardi G.S., Houthuijs D., Steerenberg P.A., et al. Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol 2000, 12(Suppl 4):1-14.
64. Mills N.L., Donaldson K., Hadoke P.W., et al. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med 2009, 6:36-44.
65. Rioux C.L., Tucker K.L., Mwamburi M., Gute D.M., Cohen S.A., Brugge D. Residential traffic exposure, pulse pressure, and C-reactive protein: consistency and contrast among exposure characterization methods. Environ Health Perspect 2010, 118:803-811.
66. Scapellato M.L., Lotti M. Short-term effects of particulate matter: an inflammatory mechanism?. Crit Rev Toxicol 2007, 37:461-487.
67. van Eeden S.F., Hogg J.C. Systemic inflammatory response induced by particulate matter air pollution: the importance of bone-marrow stimulation. J Toxicol Environ Health A 2002, 65:1597-1613.
68. van Eeden S.F., Tan W.C., Suwa T., et al. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med 2001, 164:826-830.
69. Williams L.A., Ulrich C.M., Larson T., et al. Proximity to traffic, inflammation, and immune function among women in the Seattle, Washington, area. Environ Health Perspect 2009, 117:373-378.
70. Jalava P.I., Hirvonen M.R., Sillanpaa M., et al. Associations of urban air particulate composition with inflammatory and cytotoxic responses in RAW 246.7 cell line. Inhal Toxicol 2009, 21:994-1006.
71. Sawyer K., Mundandhara S., Ghio A.J., Madden M.C. The effects of ambient particulate matter on human alveolar macrophage oxidative and inflammatory responses. J Toxicol Environ Health A 2010, 73:41-57.
72. Park E.J., Roh J., Kim Y., Park K., Kim D.S.., Yu S.D. PM 2.5 collected in a residential area induced Th1-type inflammatory responses with oxidative stress in mice. Environ Res 2011, 111:348-355.
73. Hesterberg T.W., Bunn W.B., McClellan R.O., Hamade A.K., Long C.M., Valberg P.A. Critical review of the human data on short-term nitrogen dioxide (NO2) exposures: evidence for NO2 no-effect levels. Crit Rev Toxicol 2009, 39:743-781.
74. Nell S., Suerbaum S., Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010, 8:564-577.
75. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007, 104:13780-13785.
76. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu Rev Immunol 2010, 28:573-621.
77. Fazeli M., Hassanzadeh P., Alaei S. Cadmium chloride exhibits a profound toxic effect on bacterial microflora of the mice gastrointestinal tract. Hum Exp Toxicol 2011, 30:152-159.
78. Kramar L.V. The intestinal microenvironment in healthy persons under the technogenic action of an industrial city. Vestn Ross Akad Med Nauk 2002, 37-40.
79. Targan S.R., Shanahan F., Karp L.C. Inflammatory bowel disease: from bench to bedside 2003, Springer, United States of America.